Stream B – Working with families and people with lived experience
North East and North Cumbria TCP’s Confirm and Challenge Group explain their role and explore co-production methods with the audience.
We live in the communities we serve and have stepped through the front door of senior care locations throughout the Quad Cities, Des Moines, and Iowa City/Cedar Rapids regions. We are not representatives for any of them. Instead, we act as YOUR representative . https://livwellseniors.com/about/why-choose-livwell
Why do you choose to work at Ascentria? What are you most passionate about in your job? How do you live our values of Courage, Compassion and Integrity in your daily work?
My presentation from the #6 Cross Government Accessibility Meet Up #A11yGov. Where do we start with accessible digital public services? A journey from understanding individual circumstances and crises to full digital public service use
We live in the communities we serve and have stepped through the front door of senior care locations throughout the Quad Cities. https://livwellseniors.com/about/why-choose-livwell/
Kellie Woodley of Skills for People outlines the help and Connect model which is transforming their advocacy practice. She also outlines emerging problems in personalisation in social care.
We live in the communities we serve and have stepped through the front door of senior care locations throughout the Quad Cities, Des Moines, and Iowa City/Cedar Rapids regions. We are not representatives for any of them. Instead, we act as YOUR representative . https://livwellseniors.com/about/why-choose-livwell
Why do you choose to work at Ascentria? What are you most passionate about in your job? How do you live our values of Courage, Compassion and Integrity in your daily work?
My presentation from the #6 Cross Government Accessibility Meet Up #A11yGov. Where do we start with accessible digital public services? A journey from understanding individual circumstances and crises to full digital public service use
We live in the communities we serve and have stepped through the front door of senior care locations throughout the Quad Cities. https://livwellseniors.com/about/why-choose-livwell/
Kellie Woodley of Skills for People outlines the help and Connect model which is transforming their advocacy practice. She also outlines emerging problems in personalisation in social care.
Interested in joining our company? Have a desire to work at a unique medical practice where you know what is expected of you and how you fit? Watch this slide deck to understand our culture.
Jim Proce - Credibility, Hard Questions, &Trust - 2018 PWX Presentation (vers...Jim Proce
Based on the article of the same name, published in December of 2017, Jim Proce presents the topic at APWA 2018 PWX and TPWA 2018. Credibility, Hard Questions and Trust!
Colorado Solutions provides options for people with intellectual disabilities by offering them welcoming and secure residential homes and dynamic day program services.
Realising the Potential of Consumer Directed CareCitizen Network
Simon Duffy ran this workshop for COTA Australia and Home Care Today to explore how best to build on the opportunities created by Consumer Directed Care as it is implemented in Aged Care.
It’s a simple fact that the key to Supervison is understanding people. It’s also true that understanding people is not simple. This module focuses on some of the key concepts of understanding people. Do not try to decide which is the one best way to understand people. All of these concepts have value and none is predominate. Note that the last page of this is instructive.
Person-Centred Recruitment and Hiring: LiveWorkPlay's Journey (So Far!)LiveWorkPlay
This session explores the LiveWorkPlay journey in developing and using person-centred practices. Supported individuals must have a say not only as to what, where, why, how, and when they are supported but also WHO will be invited into their lives. This presents a myriad of human resources challenges and opportunities!
Circles of Support workshop presented in Northampton, MA, April 2018Cheryl Ryan Chan
The Northampton Special Education Parent Advisory Council, in collaboration with Northampton Public Schools, sponsored this workshop and invited community stakeholders to begin the conversation around building an inclusive community.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
4. Our way of working
• We are called The Confirm and Challenge group
• We work together to make transforming Care
real for the citizens of the North East and North
Cumbria
• We include people who are in hospital, in
secure services, in the community, including
families and carer’s
• We try and keep up to date with what work is
happening and how this is affecting people’s
lives
• We say what we think is working and not
working, and tell the bosses this, over and over
and over again if this is needed
5. So why involve people, when…..
It is hard to
include people
It takes much
longer
Professionals have
people’s best
interests at heart
need to do it fast
don’t know how to
do it very it well
we think it is
cheaper
People may not
understand
Its stressful for
people and they
can’t cope with it
6. Have you heard that before?
Have you said that before?
Discussion
7. We believe
• In having choices
• Being listened to
• In having Rights
• In having a voice
• In freedom
• Deciding who you live with and where
you live is your decision
• The importance of including families
8. Tell us what you believe
2 each on the post it notes
9. How are you involved, or how do you involve people?
11. Working together
We are trying to change the way
CTR’s work in our area
We are checking if people have good
lives not just different lives
We are helping people think about
being citizens and what this means
People’s confidence have grown and
they can speak up for their rights
We have helped people have a say in
what transforming care means locally
We make sure that people and
families voice is at the table
We challenge when things are not
right
12. What we would like
people to remember
• Professional don’t always get it right, even
when they are trying hard
• People know what they want in life
• People can take control and make decisions
• Helping doesn’t mean controlling people
• People have ideas and solutions that
professionals wouldn’t even think about
• Peoples lives might have been very different
to yours, it might be hard for professionals
to see what can work for them.